The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Prostate-Specific Antigen–Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force
Open accessAbstract
Importance: Prostate cancer is the second leading cause of cancer death among US men. Objective: To systematically review evidence on prostate-specific antigen (PSA)-based prostate cancer screening, treatments for localized prostate cancer, and prebiopsy risk calculators to inform the US Preventive Services Task Force. Data Sources: Searches of PubMed, EMBASE, Web of Science, and Cochrane Registries and Databases from July 1, 2011, through July 15, 2017, with a surveillance search on February 1, 2018. Study Selection: English-language reports of randomized clinical trials (RCTs) of screening; cohort studies reporting harms; RCTs and cohort studies of active localized cancer treatments vs conservative approaches (eg, active surveillance, watchful waiting); external validations of prebiopsy risk calculators to identify aggressive cancers. Data Extraction and Synthesis: One investigator abstracted data; a second checked accuracy. Two investigators independently rated study quality. Main Outcomes and Measures: Prostate cancer and all-cause mortality; false-positive screening results, biopsy complications, overdiagnosis; adverse effects of active treatments. Random-effects meta-analyses were conducted for treatment harms. Results: Sixty-three studies in 104 publications were included (N = 1 904 950). Randomization to PSA screening was not associated with reduced risk of prostate cancer mortality in either a US trial with substantial control group contamination (n = 76 683) or a UK trial with low adherence to a single PSA screen (n = 408 825) but was associated with significantly reduced prostate cancer mortality in a European trial (n = 162 243; relative risk [RR], 0.79 [95% CI, 0.69-0.91]; absolute risk reduction, 1.1 deaths per 10 000 person-years [95% CI, 0.5-1.8]). Of 61 604 men screened in the European trial, 17.8% received false-positive results. In 3 cohorts (n = 15 136), complications requiring hospitalization occurred in 0.5% to 1.6% of men undergoing biopsy after abnormal screening findings. Overdiagnosis was estimated to occur in 20.7% to 50.4% of screen-detected cancers. In an RCT of men with screen-detected prostate cancer (n = 1643), neither radical prostatectomy (hazard ratio [HR], 0.63 [95% CI, 0.21-1.93]) nor radiation therapy (HR, 0.51 [95% CI, 0.15-1.69]) were associated with significantly reduced prostate cancer mortality vs active monitoring, although each was associated with significantly lower risk of metastatic disease. Relative to conservative management, radical prostatectomy was associated with increased risk of urinary incontinence (pooled RR, 2.27 [95% CI, 1.82-2.84]; 3 trials; n = 1796) and erectile dysfunction (pooled RR, 1.82 [95% CI, 1.62-2.04]; 2 trials; n = 883). Relative to conservative management (8 cohort studies; n = 3066), radiation therapy was associated with increased risk of erectile dysfunction (pooled RR, 1.31 [95% CI, 1.20-1.42]). Conclusions and Relevance: PSA screening may reduce prostate cancer mortality risk but is associated with false-positive results, biopsy complications, and overdiagnosis. Compared with conservative approaches, active treatments for screen-detected prostate cancer have unclear effects on long-term survival but are associated with sexual and urinary difficulties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · BMJ · doi:10.1136/bmj.g7594 · Cited by 4,388
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2014.639 · Cited by 3,293
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0697 · Cited by 3,267
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J. L., Lane, J. A., Mason, M., Metcalfe, C., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,640
Moons, K. G. M., de Groot, J. A. H., Bouwmeester, W., Vergouwe, Y., Mallett, S., Altman, D. G., Reitsma, J. B., & Collins, G. S. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001744 · Cited by 2,018
Radical Prostatectomy versus Observation for Localized Prostate Cancer
Wilt, T. J., Brawer, M. K., Jones, K. M., Barry, M. J., Aronson, W. J., Fox, S., Gingrich, J. R., Wei, J. T., Gilhooly, P., Grob, B. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113162 · Cited by 1,770
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Määttänen, L., Lilja, H., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60525-0 · Cited by 1,566
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
Donovan, J. L., Hamdy, F. C., Lane, J. A., Mason, M., Metcalfe, C., Walsh, E., Blazeby, J. M., Peters, T. J., Holding, P., Bonnington, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606221 · Cited by 1,338
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Isaacs, C., Kvale, P. A., Reding, D. J., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr500 · Cited by 1,121
Draisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Quality-of-life outcomes in men treated for localized prostate cancer
Litwin, M. S., Hays, R. D., Fink, A., Ganz, P. A., Leake, B., Leach, G. E., & Brook, R. H. (1995) · JAMA · doi:10.1001/jama.1995.03520260051032 · Cited by 1,020
Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Garmo, H., Rider, J. R., Taari, K., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Spångberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311593 · Cited by 981
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
Hugosson, J., Carlsson, S., Aus, G., Bergdahl, S., Khatami, A., Lodding, P., Pihl, C.-G., Stranne, J., Holmberg, E., & Lilja, H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70146-7 · Cited by 936
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer
Patz, E. F., Pinsky, P., Gatsonis, C., Sicks, J. D., Kramer, B. S., Tammemägi, M. C., Chiles, C., Black, W. C., & Aberle, D. R. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12738 · Cited by 776
Miller, A. B., Wall, C., Baines, C. J., Sun, P., To, T., & Narod, S. A. (2014) · BMJ · doi:10.1136/bmj.g366 · Cited by 702
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer
Wilt, T. J., Jones, K. M., Barry, M. J., Andriole, G. L., Culkin, D., Wheeler, T., Aronson, W. J., & Brawer, M. K. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615869 · Cited by 623
Welch, H. G., & Albertsen, P. C. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp278 · Cited by 575
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Prevention and early detection of prostate cancer
Cuzick, J., Thorat, M. A., Andriole, G., Brawley, O. W., Brown, P. H., Culig, Z., Eeles, R. A., Ford, L. G., Hamdy, F. C., Holmberg, L., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70211-6 · Cited by 495
Martin, R. M., Donovan, J. L., Turner, E. L., Metcalfe, C., Young, G. J., Walsh, E. I., Lane, J. A., Noble, S., Oliver, S. E., Evans, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.0154 · Cited by 415
Johansson, E., Steineck, G., Holmberg, L., Johansson, J.-E., Nyberg, T., Ruutu, M., & Bill-Axelson, A. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70162-0 · Cited by 360
Barocas, D. A., Alvarez, J., Resnick, M. J., Koyama, T., Hoffman, K. E., Tyson, M. D., Conwill, R., McCollum, D., Cooperberg, M. R., Goodman, M., et al. (2017) · JAMA · doi:10.1001/jama.2017.1704 · Cited by 344
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016
Carroll, P. R., Parsons, J. K., Andriole, G., Bahnson, R. R., Castle, E. P., Catalona, W. J., Dahl, D. M., Davis, J. W., Epstein, J. I., Etzioni, R. B., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0060 · Cited by 342
Zackrisson, S., Andersson, I., Janzon, L., Manjer, J., & Garne, J. P. (2006) · BMJ · doi:10.1136/bmj.38764.572569.7c · Cited by 341
Chen, R. C., Basak, R., Meyer, A.-M., Kuo, T.-M., Carpenter, W. R., Agans, R. P., Broughman, J. R., Reeve, B. B., Nielsen, M. E., Usinger, D. S., et al. (2017) · JAMA · doi:10.1001/jama.2017.1652 · Cited by 325
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Wong, Y.-N., Mitra, N., Hudes, G., Localio, R., Schwartz, J. S., Wan, F., Montagnet, C., & Armstrong, K. (2006) · JAMA · doi:10.1001/jama.296.22.2683 · Cited by 305
Rosario, D. J., Lane, J. A., Metcalfe, C., Donovan, J., Doble, A., Goodwin, L., Davis, M., Catto, J. W. F., AVERY, K. N. L., Neal, D. E., et al. (2012) · BMJ · doi:10.1136/bmj.d7894 · Cited by 294
Smith, D. P., King, M. T., Egger, S., Berry, M. P., Stricker, P. D., Cozzi, P., Ward, J., O'Connell, D. L., & Armstrong, B. K. (2009) · BMJ · doi:10.1136/bmj.b4817 · Cited by 286
Schröder, F. H., Hugosson, J., Carlsson, S., Tammela, T., Määttänen, L., Auvinen, A., Kwiatkowski, M., Recker, F., & Roobol, M. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.068 · Cited by 270
Pinsky, P. F., Prorok, P. C., Yu, K., Kramer, B. S., Black, A., Gohagan, J. K., Crawford, E. D., Grubb, R. L., & Andriole, G. L. (2017) · Cancer · doi:10.1002/cncr.30474 · Cited by 256
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials
Tsodikov, A., Gulati, R., Heijnsdijk, E. A. M., Pinsky, P. F., Moss, S. M., Qiu, S., de Carvalho, T. M., Hugosson, J., Berg, C. D., Auvinen, A., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2586 · Cited by 251
Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study
Stattin, P., Holmberg, E., Johansson, J.-E., Holmberg, L., Adolfsson, J., Hugosson, J., & Sweden, O. B. O. T. N. P. C. R. (. O. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq154 · Cited by 244
Ankerst, D. P., Hoefler, J., Bock, S., Goodman, P. J., Vickers, A., Hernandez, J., Sokoll, L. J., Sanda, M. G., Wei, J. T., Leach, R. J., et al. (2014) · Urology · doi:10.1016/j.urology.2014.02.035 · Cited by 236
Labrie, F., Candas, B., Cusan, L., Gomez, J. L., Bélanger, A., Brousseau, G., Chevrette, E., & Lévesque, J. (2004) · The Prostate · doi:10.1002/pros.20017 · Cited by 227
Roobol, M. J., van Vugt, H. A., Loeb, S., Zhu, X., Bul, M., Bangma, C. H., van Leenders, A. G. L. J. H., Steyerberg, E. W., & Schröder, F. H. (2012) · European Urology · doi:10.1016/j.eururo.2011.11.012 · Cited by 217
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods
Carter, J. L., Coletti, R. J., & Harris, R. P. (2015) · BMJ · doi:10.1136/bmj.g7773 · Cited by 207
Alibhai, S. M. H., Leach, M., Tomlinson, G., Krahn, M. D., Fleshner, N., Holowaty, E., & Naglie, G. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji313 · Cited by 204
Rabbani, F., Yunis, L. H., Pinochet, R., Nogueira, L., Vora, K. C., Eastham, J. A., Guillonneau, B., Laudone, V., Scardino, P. T., & Touijer, K. (2010) · European Urology · doi:10.1016/j.eururo.2009.11.034 · Cited by 187
An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis
Kiciński, M., Vangronsveld, J., & Nawrot, T. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027130 · Cited by 181
Lubeck, D. P., Litwin, M. S., Henning, J. M., Stoddard, M. L., Flanders, S. C., & Carroll, P. R. (1999) · Urology · doi:10.1016/s0090-4295(98)00408-7 · Cited by 169
Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening
Croswell, J. M., Kramer, B. S., Kreimer, A. R., Prorok, P. C., Xu, J.-L., Baker, S. G., Fagerstrom, R. M., Riley, T. L., Clapp, J. D., Berg, C. D., et al. (2009) · The Annals of Family Medicine · doi:10.1370/afm.942 · Cited by 167
Yao, S.-L., & Lu-Yao, G. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.22.1950 · Cited by 166
Hoffman, R. M., Hunt, W. C., Gilliland, F. D., Stephenson, R. A., & Potosky, A. L. (2003) · Cancer · doi:10.1002/cncr.11233 · Cited by 162
Basosquamous carcinoma: Analysis of prognostic factors influencing recurrence
Martin, R. C. G., Edwards, M. J., Cawte, T., Sewell, C. L., & McMasters, K. M. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000315)88:6<1454::aid-cncr25>3.0.co;2-s · Cited by 155
Pinsky, P. F., Black, A., Kramer, B. S., Miller, A. B., Prorok, P. C., & Berg, C. D. (2010) · Clinical Trials · doi:10.1177/1740774510374091 · Cited by 145
Screening and Prostate-Cancer Mortality in a Randomized European Study
Lawton, C. A. (2010) · Yearbook of Oncology · doi:10.1016/s1040-1741(09)79428-x · Cited by 138
Bacon, C. G., Giovannucci, E. L., Testa, M. A., & Kawachi, I. I. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65679-0 · Cited by 134
THE DEVELOPMENT OF ERECTILE DYSFUNCTION IN MEN TREATED FOR PROSTATE CANCER
Siegel, T. S., Moul, J. W., Spevak, M., Alvord, W. G., & Costabile, R. A. (2001) · The Journal of Urology · doi:10.1097/00005392-200102000-00019 · Cited by 133
Albertsen, P. C., Hanley, J. A., Penson, D. F., Barrows, G. H., & Fine, J. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.10.051 · Cited by 132
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Kilpeläinen, T. P., Tammela, T. L. J., Malila, N. K., Hakama, M., Santti, H., Määttänen, L., Stenman, U., Kujala, P. M., & Auvinen, A. P. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt038 · Cited by 112
McNaughton‐Collins, M., Fowler, F. J., Caubet, J.-F., et al. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.036 · Cited by 102
Prospective Multi-Institutional Study Evaluating the Performance of Prostate Cancer Risk Calculators
Nam, R. K., Kattan, M. W., Chin, J. L., Trachtenberg, J., Singal, R. K., Rendon, R., Klotz, L. H., Sugar, L., Sherman, C., Izawa, J. I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.6371 · Cited by 102
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
Wolters, T., Roobol, M. J., Steyerberg, E. W., van den Bergh, R. C. N., Bangma, C. H., Hugosson, J., Ciatto, S., Kwiatkowski, M., Villers, A. A., Lujan, M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24870 · Cited by 99
Poyet, C., Nieboer, D., Bhindi, B., Kulkarni, G. S., Wiederkehr, C., Wettstein, M. S., Largo, R., Wild, P. J., Sulser, T., & Hermanns, T. (2015) · British Journal of Urology · doi:10.1111/bju.13314 · Cited by 95
Effect of Treatment on Quality of Life Among Men With Clinically Localized Prostate Cancer
Schapira, M. M., Lawrence, W., Katz, D. A., McAuliffe, T. L., & Nattinger, A. B. (2001) · Medical Care · doi:10.1097/00005650-200103000-00005 · Cited by 93
Zappa, M., Ciatto, S., Bonardi, R., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008492013196 · Cited by 92
Litwin, M. S., Lubeck, D. P., Spitalny, G. M., Henning, J. M., & Carroll, P. R. (2002) · Cancer · doi:10.1002/cncr.10651 · Cited by 91
Schymura, M. J., Kahn, A. R., German, R. R., Hsieh, M., Cress, R. D., Finch, J. L., Fulton, J. P., Shen, T., & Stuckart, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-152 · Cited by 80
Foley, R. W., Maweni, R. M., Gorman, L., Murphy, K., Lundon, D., Durkan, G. C., POWER, R. E., O’Brien, F., O’Malley, K. J., Galvin, D., et al. (2016) · British Journal of Urology · doi:10.1111/bju.13437 · Cited by 80
Fowler, F. J., Barry, M. J., Walker-Corkery, B., Caubet, J.-F., Bates, D. W., Lee, J. M., Hauser, A., & McNaughton‐Collins, M. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00464.x · Cited by 79
Fransson, P., Damber, J., Tomić, R., Modig, H. G., Nyberg, G. F., & Widmark, A. (2001) · Cancer · doi:10.1002/1097-0142(20011215)92:12<3111::aid-cncr10160>3.0.co;2-e · Cited by 77
Health Perceptions in Patients Who Undergo Screening and Workup for Prostate Cancer
Katz, D. A., Jarrard, D. F., McHorney, C. A., Hillis, S. L., Wiebe, D. A., & Fryback, D. G. (2007) · Urology · doi:10.1016/j.urology.2006.09.059 · Cited by 61
Brindle, L. A., Oliver, S. E., Dedman, D., Donovan, J., Neal, D. E., Hamdy, F. C., Lane, J. A., & Peters, T. J. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06401.x · Cited by 55
Kang, L., Croswell, J. M., Koenig, H. C., Lam, C., & Maltz, A. (2011) · Europe PMC (PubMed Central) · Cited by 52
Young, G., Harrison, S., Turner, E. L., Walsh, E. I., Oliver, S. E., Ben‐Shlomo, Y., Evans, S., Lane, J. A., Neal, D. E., Hamdy, F. C., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017729 · Cited by 50
Thong, M. S. Y., Mols, F., Kil, P. J. M., Korfage, I. J., & van de Poll-Franse, L. V. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08815.x · Cited by 46
Hernandez, D. J., Han, M., Humphreys, E. B., Mangold, L. A., Taneja, S. S., Childs, S. J., Bartsch, G. C., & Partin, A. W. (2009) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.08127.x · Cited by 44
Ankerst, D. P., Boeck, A., Freedland, S. J., Jones, J. S., Cronin, A. M., Roobol, M. J., Hugosson, J., Kattan, M. W., Klein, E. A., Hamdy, F. C., et al. (2012) · World Journal of Urology · doi:10.1007/s00345-012-0869-2 · Cited by 43
Martin, R., Donovan, J., Turner, E., Metcalfe, C., Young, G., Walsh, E., Lane, J., Noble, S., Oliver, S., Evans, S., et al. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.24935 · Cited by 33
Fransson, P., Damber, J., & Widmark, A. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590802519396 · Cited by 32
Radiotherapy and Survival in Prostate Cancer Patients: A Population-Based Study
Zhou, E. H., Ellis, R. J., Cherullo, E. E., Colussi, V., Xu, F., Chen, W.-D. D., Gupta, S., Whalen, C. C., Bodner, D. R., Resnick, M. I., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.001 · Cited by 31
Ngo, T. C., Turnbull, B. B., Lavori, P. W., & Presti, J. C. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.09.101 · Cited by 21
Gómez‐Gómez, E., Carrasco‐Valiente, J., Blanca, A., Barco-Sánchez, B., Fernández-Rueda, J. L., Molina‐Abril, H., Valero-Rosa, J., Font, P., & Requena-Tapia, M. J. (2016) · Urology · doi:10.1016/j.urology.2016.11.004 · Cited by 18
Park, J. Y., Yoon, S., Park, M. S., Choi, H., Bae, J. H., Moon, D. G., Hong, S. K., Lee, S. E., Park, C., & Byun, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168917 · Cited by 13
Maruf, M., Fascelli, M., George, A. K., Siddiqui, M. M., Kongnyuy, M., DiBianco, J. M., Muthigi, A., Valayil, S., Sidana, A., Frye, T. P., et al. (2017) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2016.46 · Cited by 4
Cited by
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21708 · Cited by 17,196
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Mottet, N., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Cumberbatch, M. G., De Santis, M., Fanti, S., Fossati, N., Gandaglia, G., Gillessen, S., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.09.042 · Cited by 2,802
Metadata
- Authors
- Fenton, J. J., Weyrich, M. S., Durbin, S., Liu, Y., Bang, H., & Melnikow, J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-05-08
- Volume
- 319
- Issue
- 18
- Pages
- 1914
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2800738672
- Cited by
- 555
- References
- 79
- FWCI
- 40.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.